Beijing Tiantan Biological Products Corp Ltd (600161) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, Beijing Tiantan Biological Products Corp Ltd (600161) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥318.80 Million ≈ $46.65 Million USD) by net assets (CN¥14.95 Billion ≈ $2.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Beijing Tiantan Biological Products Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Beijing Tiantan Biological Products Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Beijing Tiantan Biological Products Corp (600161) total liabilities for a breakdown of total debt and financial obligations.

Beijing Tiantan Biological Products Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Tiantan Biological Products Corp Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Suzhou Novosense Microelectronics Co. Ltd. SHG:688052	-0.027x
Warner Music Group NASDAQ:WMG	0.531x
Antar Chile SN:ANTARCHILE	0.005x
TSINGTAO BREWE. H ADR/5 F:TSI0	N/A
Ningbo Sanxing Medical Electric Co Ltd SHG:601567	0.043x
KLCC Property Holdings Bhd KLSE:5235SS	0.021x
Nordstrom Inc NYSE:JWN	0.786x
Metsera, Inc. Common Stock NASDAQ:MTSR	-0.131x

Annual Cash Flow Conversion Efficiency for Beijing Tiantan Biological Products Corp Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Beijing Tiantan Biological Products Corp worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥14.53 Billion ≈ $2.13 Billion	CN¥819.78 Million ≈ $119.96 Million	0.056x	-69.94%
2023-12-31	CN¥12.75 Billion ≈ $1.87 Billion	CN¥2.39 Billion ≈ $350.26 Million	0.188x	+89.27%
2022-12-31	CN¥11.36 Billion ≈ $1.66 Billion	CN¥1.13 Billion ≈ $164.77 Million	0.099x	+3.84%
2021-12-31	CN¥10.27 Billion ≈ $1.50 Billion	CN¥980.35 Million ≈ $143.46 Million	0.095x	-17.98%
2020-12-31	CN¥6.03 Billion ≈ $882.52 Million	CN¥702.11 Million ≈ $102.74 Million	0.116x	-6.18%
2019-12-31	CN¥5.18 Billion ≈ $757.61 Million	CN¥642.47 Million ≈ $94.01 Million	0.124x	-20.43%
2018-12-31	CN¥4.35 Billion ≈ $636.07 Million	CN¥677.92 Million ≈ $99.20 Million	0.156x	+127.40%
2017-12-31	CN¥3.18 Billion ≈ $465.96 Million	CN¥218.39 Million ≈ $31.96 Million	0.069x	-60.92%
2016-12-31	CN¥2.44 Billion ≈ $357.19 Million	CN¥428.37 Million ≈ $62.68 Million	0.175x	-17.08%
2015-12-31	CN¥2.24 Billion ≈ $327.23 Million	CN¥473.26 Million ≈ $69.25 Million	0.212x	-1.81%
2014-12-31	CN¥2.22 Billion ≈ $324.51 Million	CN¥477.95 Million ≈ $69.94 Million	0.216x	-17.19%
2013-12-31	CN¥2.18 Billion ≈ $318.46 Million	CN¥566.43 Million ≈ $82.89 Million	0.260x	+7.07%
2012-12-31	CN¥1.78 Billion ≈ $260.05 Million	CN¥432.00 Million ≈ $63.22 Million	0.243x	-0.46%
2011-12-31	CN¥1.45 Billion ≈ $211.62 Million	CN¥353.15 Million ≈ $51.68 Million	0.244x	+50.88%
2010-12-31	CN¥1.14 Billion ≈ $167.13 Million	CN¥184.85 Million ≈ $27.05 Million	0.162x	-65.73%
2009-12-31	CN¥949.13 Million ≈ $138.89 Million	CN¥448.23 Million ≈ $65.59 Million	0.472x	+29.34%
2008-12-31	CN¥756.97 Million ≈ $110.77 Million	CN¥276.39 Million ≈ $40.44 Million	0.365x	+72.54%
2007-12-31	CN¥725.57 Million ≈ $106.17 Million	CN¥153.55 Million ≈ $22.47 Million	0.212x	-2.89%
2006-12-31	CN¥708.35 Million ≈ $103.65 Million	CN¥154.36 Million ≈ $22.59 Million	0.218x	+10.72%
2005-12-31	CN¥669.09 Million ≈ $97.91 Million	CN¥131.69 Million ≈ $19.27 Million	0.197x	+13.83%
2004-12-31	CN¥636.79 Million ≈ $93.18 Million	CN¥110.11 Million ≈ $16.11 Million	0.173x	+64.78%
2003-12-31	CN¥599.70 Million ≈ $87.76 Million	CN¥62.93 Million ≈ $9.21 Million	0.105x	-64.06%
2002-12-31	CN¥289.04 Million ≈ $42.30 Million	CN¥84.38 Million ≈ $12.35 Million	0.292x	+81.90%
2001-12-31	CN¥289.68 Million ≈ $42.39 Million	CN¥46.49 Million ≈ $6.80 Million	0.160x	-6.46%
2000-12-31	CN¥279.21 Million ≈ $40.86 Million	CN¥47.90 Million ≈ $7.01 Million	0.172x	+12.68%
1999-12-31	CN¥279.67 Million ≈ $40.92 Million	CN¥42.58 Million ≈ $6.23 Million	0.152x	+70.68%
1998-12-31	CN¥265.80 Million ≈ $38.89 Million	CN¥23.71 Million ≈ $3.47 Million	0.089x	--

About Beijing Tiantan Biological Products Corp Ltd

SHG:600161 China Biotechnology

Market Cap

$4.13 Billion

CN¥28.20 Billion CNY

Market Cap Rank

#4066 Global

#689 in China

Share Price

CN¥14.26

Change (1 day)

-1.31%

52-Week Range

CN¥14.26 - CN¥21.06

All Time High

CN¥74.24